Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial space.
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Bacterial infections; Pericardial effusion
- Focus Pharmacokinetics
- 31 Mar 2012 Actual end date (Mar 2007) added as reported by European Clinical Trials Database record.
- 31 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 11 Aug 2011 New trial record